A detailed history of Verition Fund Management LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Verition Fund Management LLC holds 8,758 shares of CORT stock, worth $513,043. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,758
Previous 37,689 76.76%
Holding current value
$513,043
Previous $1.22 Million 66.91%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$29.51 - $46.26 $853,753 - $1.34 Million
-28,931 Reduced 76.76%
8,758 $405,000
Q2 2024

Aug 14, 2024

BUY
$22.21 - $34.48 $837,072 - $1.3 Million
37,689 New
37,689 $1.22 Million
Q2 2023

Aug 14, 2023

BUY
$21.44 - $25.15 $234,639 - $275,241
10,944 New
10,944 $243,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $6.27B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.